Yutiq

Active Ingredient(s): Fluocinolone Acetonide
FDA Approved: * October 12, 2018
Pharm Company: * EYEPOINT PHARMS
Category: Skin Care

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Yutiq Overview

Fluocinolone acetonide is a corticosteroid primarily used in dermatology to reduce skin inflammation and relieve itching. It is a synthetic hydrocortisone derivative. The fluorine substitution at position 9 in the steroid nucleus greatly enhances its activity. It was first synthesized in 1959 in the Research Department of Syntex Laboratories S.A. Mexico City.[1] Preparations containing it were first marketed under the name Synalar. A typical dosage strength used in dermatology...

Read more Yutiq Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Fluocinolone_acetonide

Recent Yutiq Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Fluocinolone Acetonide
  • Cream: 0.01%, 0.025%, 0.03%
  • Gel: 0.025%, 0.03%
  • Implant: 0.18mg, 0.19mg, 0.59mg
  • Insert: 0.19mg
  • Oil: 0.01%
  • Oil/drops: 0.01%
  • Ointment: 0.025%, 0.03%
  • Shampoo: 0.01%
  • Solution: 0.01%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Yutiq: (1 result)

Sorted by National Drug Code
  • 71879-136 Yutiq .18 mg Intravitreal Implant by Eyepoint Pharmaceuticals Us, Inc

Other drugs which contain Fluocinolone Acetonide or a similar ingredient: (11 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 16 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA